肺癌是我国最常见的恶性肿瘤之一。近几年,随着社会工业化进程不断扩大,空气污染日趋严重,雾霾频发,肺癌的发病率呈现出持续增长的态势。肺癌如何才能得到有效治疗是大众关注的问题。肺癌中大部分为非小细胞肺癌,很多患者在确诊时已经是晚期。既往对这类患者的治疗仍然是采取化疗的方式,但其疗效已经进入一个平台期,且其较强的副反应使得该治疗方式在临床上的应用受到限制。随着分子生物学水平的不断深入研究,肺 Lung cancer is one of the most common malignant tumors in our country. In recent years, with the continuous expansion of social industrialization, increasing air pollution, frequent haze, the incidence of lung cancer showed a continuous growth trend. How to get effective treatment of lung cancer is a public concern. Most of lung cancer is non-small cell lung cancer, many patients are already diagnosed late. Previous treatment of such patients is still the way to take chemotherapy, but its efficacy has entered a plateau, and its strong side effects make the treatment in clinical application is limited. With the continuous study of molecular biology level, lung